What does CUSIP 03969K108 represent in this 13F holders report?

CUSIP 03969K108 is the security identifier for ARQT - Arcutis Biotherapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in Q4 2020?

78 institutional investors reported ARQT - Arcutis Biotherapeutics, Inc. - Common Stock for Q4 2020. Use the holders table for investor-level position and value details.

Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)

CUSIP: 03969K108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock
Shares outstanding: 122,541,881
Total 13F shares: 40,973,719
Share change: +4,927,752
Total reported value: $1,152,598,120
Price per share: $28.13
Number of holders: 78
Value change: +$138,537,380
Number of buys: 50
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 03969K108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRAZIER MANAGEMENT LLC	13F	Company	8.6%	10,542,790	$308,904,000	—	30 Sep 2020	13F
FMR LLC	13F	Company	4.7%	5,728,393	$167,842,000	—	30 Sep 2020	13F
ORBIMED ADVISORS LLC	13F	Company	3.8%	4,673,850	$136,944,000	—	30 Sep 2020	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	3.2%	3,979,292	$116,593,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	1.7%	2,056,386	$60,253,000	—	30 Sep 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.95%	1,165,184	$34,140,000	—	30 Sep 2020	13F
Vivo Capital, LLC	13F	Company	0.91%	1,113,265	$32,619,000	—	30 Sep 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.81%	991,021	$29,037,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	0.7%	857,166	$25,115,000	—	30 Sep 2020	13F
Omega Fund Management, LLC	13F	Company	0.54%	658,908	$19,306,000	—	30 Sep 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.45%	556,363	$16,301,000	—	30 Sep 2020	13F
Polar Capital LLP	13F	Company	0.29%	350,000	$10,255,000	—	30 Sep 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.23%	284,446	$8,334,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	0.22%	265,434	$7,777,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	247,913	$7,263,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.17%	210,268	$6,162,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.15%	179,376	$5,256,000	—	30 Sep 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	110,623	$3,242,000	—	30 Sep 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	75,664	$2,217,000	—	30 Sep 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	68,380	$2,003,000	—	30 Sep 2020	13F
Bank of New York Mellon Corp	13F	Company	0.05%	56,611	$1,659,000	—	30 Sep 2020	13F
Laurion Capital Management LP	13F	Company	0.04%	50,000	$1,465,000	—	30 Sep 2020	13F
ALPS ADVISORS INC	13F	Company	0.04%	48,694	$1,427,000	—	30 Sep 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.04%	43,256	$1,267,000	—	30 Sep 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	40,881	$1,198,000	—	30 Sep 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.03%	33,797	$990,000	—	30 Sep 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	30,642	$898,000	—	30 Sep 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	27,357	$802,000	—	30 Sep 2020	13F
STIFEL FINANCIAL CORP	13F	Company	0.02%	23,748	$696,000	—	30 Sep 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.02%	21,876	$641,000	—	30 Sep 2020	13F
Swiss National Bank	13F	Company	0.02%	21,300	$624,000	—	30 Sep 2020	13F
NORGES BANK	13F	Company	0.02%	21,116	$619,000	—	30 Sep 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	20,474	$600,000	—	30 Sep 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	16,975	$497,000	—	30 Sep 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.01%	16,000	$469,000	—	30 Sep 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	15,350	$450,000	—	30 Sep 2020	13F
Maven Securities LTD	13F	Company	0.01%	15,000	$433,000	—	30 Sep 2020	13F
DUPONT CAPITAL MANAGEMENT CORP	13F	Company	0.01%	13,268	$389,000	—	30 Sep 2020	13F
VIRTUS ADVISERS, LLC	13F	Company	0.01%	12,081	$354,000	—	30 Sep 2020	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.01%	11,691	$343,000	—	30 Sep 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	11,340	$332,000	—	30 Sep 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	10,959	$321,000	—	30 Sep 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	10,810	$317,000	—	30 Sep 2020	13F
CITIGROUP INC	13F	Company	0.01%	9,884	$290,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	9,815	$288,000	—	30 Sep 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	9,776	$286,000	—	30 Sep 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	9,400	$275,000	—	30 Sep 2020	13F
MetLife Investment Management, LLC	13F	Company	0.01%	8,244	$241,549	—	30 Sep 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	6,739	$209,000	—	30 Sep 2020	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0%	5,660	$165,838	—	30 Sep 2020	13F

Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q4 2020

As of 31 Dec 2020, Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,973,719 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, FMR LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, Point72 Asset Management, L.P., Vivo Capital, LLC, and STATE STREET CORP. This page lists 78 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.